GuillaumeBonhoure

Associate

巴黎 + 33.1.56.59.38.99

聯絡

*Share

Guillaume Bonhoure's practice areas includes venture capital, private equity, M&A, and capital markets.

Prior to joining Jones Day in 2023, Guillaume was an associate at a leading French law firm in Paris, where his practice focused on M&A transactions for listed and unlisted companies, securities law, corporate governance, and corporate law. He also completed an internship at the French financial markets authority (Autorité des marchés financiers).

執業經驗

  • Swiss Diabetes Venture Fund participates in €7 million financing of BOYDSenseJones Day advised Swiss Diabetes Venture Fund, lead investor with Bioserenity, in the €7 million financing of BOYDSense, a French medical device company that is developing a non-invasive glucose monitoring device via exhaled breath.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Vibe.co raises $22.5 million in Series A fundingJones Day advised Vibe.co, an operator of a programmatic advertising space buying platform that enables brands to broadcast and run their own advertising campaigns on connected TVs and other applications that deliver video content, in its $22.5 million Series A funding led by Singular.
  • TiLT Capital Partners leads €46 million financing of EODevJones Day advised TiLT Capital Partners SAS in leading the €46 million financing of EODev, along with Supernova Invest, CapHorn, Pulse (CMA-CGM), and the existing shareholders of EODev, to strengthen its leading position in the hydrogen fuel cell power generators market by financing its investment program, the expansion of its product range, and the acceleration of its commercial development.
    •

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.